Hospitalar 2026: A Successful Show in São Paulo

Hospitalar 2026: Connecting with Partners Across Latin America

São Paulo, Brazil

Microprofit Biotech is pleased to announce the successful conclusion of its participation in Hospitalar 2026, Latin America's largest and most influential healthcare trade fair, held from May 19 to 22 at the São Paulo Expo.

Over the course of four dynamic days, our team welcomed a steady stream of distributors, clinicians, and healthcare partners to Booth E-420a, where we showcased the breadth of our fluorecare® diagnostic portfolio.

Spotlight on Innovation

This year, two solutions drew particular attention from visitors:

fluorecare® FIA Quantitative POCT Platform — Demonstrating its ability to deliver laboratory-grade quantitative results in a compact, easy-to-use format, the platform resonated strongly with clinics and laboratories seeking to decentralize testing without compromising accuracy.

Respiratory Infections Rapid Test Solutions — Reflecting the rising demand for rapid, multi-pathogen respiratory screening, our solutions sparked extensive discussion around improving early detection and patient management in the region.

Building Partnerships in Latin America

Beyond product demonstrations, Hospitalar 2026 provided an invaluable platform to deepen relationships with our long-standing partners and to establish new connections across the Brazilian and broader Latin American markets. The conversations underscored a shared commitment to advancing accessible, point-of-care diagnostics.

"The energy and engagement we experienced at Hospitalar this year reaffirm the growing role of point-of-care testing in Latin America," said the Microprofit Biotech team. "We are deeply grateful to everyone who visited us, and we look forward to turning these conversations into lasting partnerships."

Looking Ahead

Microprofit Biotech extends its sincere thanks to all visitors, partners, and organizers who made this event a success. We remain committed to empowering healthcare providers worldwide with fast, reliable, and accessible diagnostic solutions.

For partnership inquiries or more information about our fluorecare® product range, please visit www.microprofit-bio.com or contact our international team.

About Microprofit Biotech

Shenzhen Microprofit Biotech Co., Ltd. is a leading developer and manufacturer of in-vitro diagnostic (IVD) solutions. Through its fluorecare® brand, the company delivers high-quality Point-of-Care Testing (POCT) products to over 100 countries, supporting decentralized and accessible healthcare worldwide.